The revenue stands at ₹1,353.73 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.92 per cent from ₹1,302.65 crore. This corresponds to a year-on-year *(YoY) growth of 14.08 per cent.
Operating Profit stands at ₹62.73 crore, reflecting a quarter-on-quarter *(QoQ) increase of 98.58 per cent from ₹31.59 crore. This corresponds to a year-on-year *(YoY) growth of 146.00 per cent.
PBDT stands at ₹123.59 crore, reflecting a quarter-on-quarter *(QoQ) increase of 5.56 per cent from ₹117.08 crore. This corresponds to a year-on-year *(YoY) growth of 14.28 per cent.
Profit Before Tax stands at ₹340.81 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.92 per cent from ₹331.13 crore. This corresponds to a year-on-year *(YoY) growth of 17.42 per cent.
Net Profit stands at ₹260.19 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.90 per cent from ₹255.34 crore. This represents a 20.19 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Ajanta Pharma | 0.00% | 9.30% | 11.82% | 20.78% | 9.27% | -0.41% |
| Biocon | 1.42% | 0.77% | 1.29% | 13.25% | 3.45% | 9.66% |
| Glaxosmi. Pharma | 1.21% | 0.34% | -0.97% | -9.17% | -24.37% | 12.79% |
| Anthem Bioscienc | 2.36% | 1.95% | -1.12% | -14.39% | -10.44% | -10.44% |
| Ipca Labs. | 0.29% | -2.28% | -3.85% | 6.00% | -1.67% | -18.48% |
| J B Chemicals & | 1.62% | 2.49% | 1.17% | 11.01% | 12.67% | 0.90% |
| Gland Pharma | -0.30% | 3.82% | -1.04% | -11.68% | -8.59% | -9.37% |
Chairman (Non-Executive) : Mannalal B Agrawal
Vice Chairman : Madhusudan B Agrawal
Managing Director : Yogesh Agrawal
Vice President & Company Secretary : Gaurang Shah
Joint Managing Director : Rajesh M Agrawal
Independent Director : David Rasquinha
Independent Director : Medha Joshi
Independent Director : Simi Thapar
Independent Director : Rajesh Shashikant Dalal